Avsnitt

  • The anti-rejection drug rapamycin has been shown in mice and other mammals to reverse cellular damage caused by aging to extend healthy life by up to 20%. This has caused massive off-label prescribing and use of rapamycin in humans as an anti-aging drug.

    The GameChanger
    What do you tell patients about the evidence-based use of rapamycin for anti-aging?

    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    https://www.washingtonpost.com/business/2024/03/15/rapamycin-longevity-drug/

    https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00258-1/fulltext

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Describe the mechanism of action of rapamycin and how it may reverse normal aging.
    2. Discuss the current state of evidence of rapamycin for this indication and its safety concerns.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-129-H01-P
    Initial release date: 03/25/2024
    Expiration date: 03/25/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • In this episode, we delve into the crucial topic of understanding generational differences in the context of pharmacy education. Our guest expert, Melissa Medina from the University of Oklahoma, brings a wealth of knowledge and experience to the table, shedding light on why grasping these generational nuances is paramount for preceptors working with pharmacy students and residents.

    Tune in to gain a fresh perspective on how everyone can win and learn by engaging across generations.

    Host
    Kathy Schott, PhD
    Vice President, Education & Operations
    CEimpact

    Guest
    Melissa Medina, Ed.D
    Interim Dean and Professor
    The University of Oklahoma Health Sciences Center College of Pharmacy

    Get CE: CLICK HERE TO GET CPE CREDIT FOR THE COURSE!

    CPE Information

    Learning Objectives
    At the end of this course, preceptors will be able to:

    Describe factors that have impacted how Generation Z p(Gen Z) pharmacy residents and student pharmacists see the world.Identify strategies for engaging effectively with Gen Z learners.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-111-H99-P
    Initial release date: 3/20/2024
    Expiration date: 3/20/2027
    Additional CPE details can be found here.

    The speakers have no relevant financial relationships with ineligible companies to disclose.
    ChatGPT 3.5 (https://chat.openai.com) was utilized in the planning of this P2P episode.

    This program has been:
    Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

    Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Saknas det avsnitt?

    Klicka här för att uppdatera flödet manuellt.


  • The GameChanger
    A new study looks at the utility of omalizumab in preventing food allergy reactions after accidental exposure.

    ACEis and Beta-blockers should be avoided in patients with recurrent anaphylaxis if possible.


    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2312382

    Anaphylaxis guideline: https://www.annallergy.org/article/S1081-1206(23)01304-2/fulltext

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss the OUtMATCH study results and their relevance to patients with food allergies.

    2. Interpret the new AAAAI anaphylaxis guidelines in relation to patient care.



    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-079-H01-P
    Initial release date: 03/18/2024
    Expiration date: 03/18/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Stay updated on recently FDA-approved medications crucial for pharmacists.
    Gain essential insights on new drugs approved in the last 12 to 18 months, ensuring accurate dispensing and effective patient education.

    The GameChanger
    SweatControl Patch approved for primary axillary hyperhidrosis.
    Update in treatment for Alzheimer's with mild cognitive impairment.


    Host
    Joe Strain, PharmD
    Clinical Faculty, Monument Health
    South Dakota State College of Pharmacy



    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss the therapeutic indications of recent FDA-approved medications.
    2. Describe unique pharmacological properties for each new medication.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-098-H01-P
    Initial release date: 03/11/2024
    Expiration date: 03/11/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • The cardiometabolic syndrome is a concept recently developed by the American Heart Association to denote the totality of risk in a patient with risk factors that may lead to or worsen chronic kidney disease or cardiovascular events. A new validated scoring system has been endorsed by AHA to better assess the short and long-term risk for these in the general population. We will discuss this scoring system in this podcast.

    The GameChanger
    A new validated scoring system has incorporated factors to better determine the 10 and 30 year risk of CVD and CKD in a general population.

    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Mathew Boyd, PharmD
    Clinical Pharmacist
    Unity Point

    Reference
    Guidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001191

    Calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Describe the concept of the Cardiovascular-Kidney-Metabolic syndrome.
    2. Discuss how the PREVENT scoring system is applied to patients.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-075-H01-P
    Initial release date: 3/4/2024
    Expiration date: 3/4/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Several outbreaks of a relatively new, resistant fungal infection - candida auris - have been reported in the Pacific Northwest. It is highly contagious and its mortality has approached 60%. Listen in as we discuss what to watch for and how to prepare if this reaches your geography.

    THE GAMECHANGER:
    Candida auris is resistant to most antifungals, has high plasticity, and its mortality approaches 60%.

    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    Cristina ML, Spagnolo AM, Sartini M, Carbone A, Oliva M, Schinca E, Boni S, Pontali E. An Overview on Candida auris in Healthcare Settings. J Fungi (Basel). 2023 Sep 8;9(9):913. doi: 10.3390/jof9090913. PMID: 37755021; PMCID: PMC10532978.

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss characteristics of C. auris infections that make it difficult to avoid outbreaks 2. Describe issues surrounding treatment of serious infections with C. auris

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-058-H01-P
    Initial release date: 2/26/2024
    Expiration date: 2/26/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Do you feel like it is getting more difficult to engage your students or residents on your rotation and keep them engaged? Or maybe you personally feel a little bored with the same old activities and strategies. In this episode, preceptors Beth Cady and Carrie Vogler of Southern Illinois University Edwardsville on some creative strategies they use to engage their learners.

    Kathy Schott, PhD
    Vice President, Education & Operations
    CEimpact

    Kate Newman, PharmD
    Director of Experiential Education
    Southern Illinois University Edwardsville

    Elizabeth Cady, PharmD
    Clinical Associate Professor
    Southern Illinois University Edwardsville

    Carrie Vogler
    Clinical Professor
    Southern Illinois University Edwardsville

    Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

    CPE Information

    Learning Objectives
    At the end of this course, preceptors will be able to:
    1. Discuss barriers to effectively engaging students and residents in their experiential learning
    2. Identify creative strategies for engaging students and residents to optimize their learning

    0.075 CEU/0.75 Hr
    UAN: 0107-0000-24-059-H99-P
    Initial release date: 2/21/2024
    Expiration date: 2/21/2027
    Additional CPE details can be found here.

    The speakers have no relevant financial relationships with ineligible companies to disclose.

    ChatGPT 3.5 (https://chat.openai.com) was utilized in the planning of this Precept2Podcast episode.

    This program has been:
    Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

    Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • With pockets of measles outbreaks throughout the country, we discuss the reasons and strategize ways pharmacy can impact vaccination rates in their communities.

    The GameChanger
    Measles was essentially eliminated from the US in 2000. Now, we are seeing a resurgence of outbreaks that have prompted the CDC to issue warnings and reminders of the importance of proper vaccination.

    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Elizabeth Skoy, PharmD
    Professor
    North Dakota State University

    Lacy Epperson, PharmD
    Clinical Pharmacist
    Mitchell’s Drug Store

    Reference
    https://www.usatoday.com/story/news/health/2024/01/26/cdc-issues-alert-measles-global/72365871007/

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Describe the CDC warning about the increased incidence of measles
    2. Discuss ways pharmacy can have an impact on increasing vaccination rates and decreasing measles outbreaks

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-057-H01-P
    Initial release date: 2/19/2024
    Expiration date: 2/19/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • With record-cold temperatures in much of the United States this winter, a high number of cold injuries have been reported. This podcast discusses prevention and treatment for hypothermia and frostbite. Brrrrr!

    The GameChangers:

    Frostbite prevention using layers and heating measuresHypothermia treatment using external and internal heating Frostbite treatment with anticoagulants


    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    https://www-nejm-org./doi/10.1056/NEJMra1800868?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Differentiate between types of hypothermia
    2. Discuss treatments for frostbite

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-051-H01-P
    Initial release date: 2/12/2024
    Expiration date: 2/12/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • The American Diabetes Association has released the 2024 Standards of Care for people with Type 1 and Type 2 Diabetes. Join us as we talk with one of our favorite diabetes experts, Dr. Sue Cornell, about the major shifts in diabetes care that are omnipresent in this year's guideline updates.

    The GameChanger
    Diabetes treatment is shifting to prevention and delay. After a long period of time without many advances, we are now on the brink of changing the game in diabetes care and prevention with new drugs and technologies.

    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Susan Cornell, PharmD, CDCES, FAPhA, FADCES
    Diabetes Care & Education Specialist
    Midwestern University College of Pharmacy

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss highlights of the 2024 American Diabetes Association Standards of Care Update
    2. Describe the landscape of diabetes care as it shifts to prevention and delay

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-050-H01-P
    Initial release date: 2/5/2024
    Expiration date: 2/5/2025
    Additional CPE details can be found here.

    Join us Tuesday, February 13th from 7-9pm for our next live course:
    From A1C to Z: A Sweet Update on Diabetes Guidelines
    This course will review the latest revisions to the American Diabetes Association (ADA) Standards of Care specifically highlighting the rising rates of obesity-related to diabetes, a pressing health concern affecting millions worldwide and often referred to as "diabesity". Learners will gain insights into nuances related to medication management and therapeutic decision-making for patients with diabetes. Content will provide guidance for reviewing and crafting patient-centered treatment strategies that holistically address glucose management while fostering improvements in cardio-metabolic, kidney, liver, and cognitive health for individuals grappling with diabetes and related comorbidities.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Insulin icodec is the first class of long-acting insulin to be administered only once a week. Join host, Jen Moulton, as she discusses the safety and efficacy of insulin icodec with guest, Geoff Wall.

    The GameChanger
    Insulin icodec is the first of the ultra long-acting insulins with once weekly dosing. Multiple clinical studies have suggested these pharmacokinetics work. A new meta-analysis suggests that insulin icodec is more effective than other basal insulins and at least as safe concerning hypoglycemia.

    Jen Moulton, RPh
    President + Founder
    CEimpact

    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    Wang P, Zhang Y, Xu W, et al. Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Diabetol Metab Syndr. 2024 Jan 3;16(1):3. doi: 10.1186/s13098-023-01240-5. PMID: 38172995; PMCID: PMC10763463.

    https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-023-01240-5#Sec19

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Explain the chemical and structural changes that make icodec different from other basal insulins
    2. Discuss the results of the meta-analysis about insulin icodec

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-043-H01-P
    Initial release date: 1/29/2024
    Expiration date: 1/29/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Alcohol Use Disorder (AUD) and cirrhosis are common medical conditions with significant morbidity and mortality. Join host, Geoff Wall, as he evaluates the new American College of Gastroenterology guidelines.

    The GameChanger
    The MELD score is now preferred over the Madrey score for assessing mortality. Baclofen is the primary treatment for reducing consumption and craving in alcohol use disorder.

    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    Jophlin LL, Singal AK, Bataller R, Wong RJ, Sauer BG, Terrault NA, Shah VH. ACG Clinical Guideline: Alcohol-Associated Liver Disease. Am J Gastroenterol. 2024 Jan 1;119(1):30-54. doi: 10.14309/ajg.0000000000002572. Epub 2023 Sep 1. PMID: 38174913.

    https://journals.lww.com/ajg/fulltext/2024/01000/acg_clinical_guideline__alcohol_associated_liver.13.aspx?context=featuredarticles&collectionid=5

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss the initial treatment of a patient admitted with acute alcoholic hepatitis
    2. Describe a pharmacotherapeutic plan for adjunctive treatment of alcohol use disorder

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-042-H01-P
    Initial release date: 1/22/2024
    Expiration date: 1/22/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Communication is ‘an essential duty’ of a pharmacist and the cornerstone of quality patient care. And yet, it continues to be one of the most common frustrations reported by preceptors when working with students and residents. Many factors may be at play, including a pandemic, as well as a digital society where so much communication happens in quick, abbreviated bytes.

    On this episode, guest Christine Klein reminds us of the many facets of communication, the complex range of reasons some students and residents may struggle, and how we as mentors and teachers can support their development in this area effectively.

    Host
    Kathy Schott, PhD
    Vice President, Education & Operations
    CEimpact

    Guest
    Dr. Christine Klein, PharmD
    Vice-Chair for Experiential Education
    Clinical Associate Professor
    Mercer University College of Pharmacy

    Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

    CPE Information

    Learning Objectives
    At the end of this course, preceptors will be able to:
    1. Discuss the importance of strong communication skills for students and residents
    2. Describe the preceptor's role in fostering professional communication

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-041-H99-P
    Initial release date: 1/17/2024
    Expiration date: 1/17/2025
    Additional CPE details can be found here.

    The speakers have no relevant financial relationships with ineligible companies to disclose.

    This program has been:
    Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

    Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Hyponatremia is a side effect of most diuretics but the incidence from thiazides is unknown. Join host, Geoff Wall, as he evaluates a new study from Denmark evaluating hyponatremia and thiazides.

    The GameChanger
    Thiazide diuretics are considered first-line therapy but electrolyte side effects are underevaluated. A new study suggests hyponatremia is significantly more common than previously reported, especially in the elderly.

    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    Andersson NW, Wohlfahrt J, Feenstra B, et al. Cumulative Incidence of Thiazide-Induced Hyponatremia: A Population-Based Cohort Study. Ann Intern Med. 2023 Dec 19. doi: 10.7326/M23-1989. Epub ahead of print. PMID: 38109740.

    https://www.acpjournals.org/doi/abs/10.7326/M23-1989?journalCode=aim

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss the use of thiazides in hypertension and their adverse effects
    2. Assess the strengths and weaknesses of the Andersson et al study

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-032-H01-P
    Initial release date: 1/15/2024
    Expiration date: 1/15/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Sickle cell disease (SCD) is a devastating medical condition causing pain, fatigue, and early mortality. Join host, Geoff Wall, as he evaluates a new gene therapy via CRISPR that may cure SCD.

    The GameChanger
    CRISPR is a new method to develop targeted gene editing treatments. Lovo-cel is the first FDA-approved therapy and may treat sickle cell disease (SCD) - for only $2 million.

    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    FDA Approval. https://www.fda.gov/vaccines-blood-biologics/lyfgenia.

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss what CRISPR is and how it can be used to treat diseases
    2. Describe the use of lovotibeglogene autotemcel (lovo-cel) for sickle cell disease and its safety and efficacy data

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-031-H01-P
    Initial release date: 1/8/2024
    Expiration date: 1/8/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, with guest Matt Boyd, as they evaluate the pharmacotherapy changes in the new guidelines in this two-part episode.

    The GameChanger
    Rate and rhythm control medications largely have the same clinical outcomes. Patients with heart failure with reduced ejection fraction should try rhythm control first. Monitoring is key for atrial fibrillation pharmacotherapy.

    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Guest
    Mathew Boyd, PharmD
    Clinical Pharmacist
    Unity Point

    Reference
    Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)06465-3. doi: 10.1016/j.jacc.2023.08.017. Epub ahead of print. PMID: 38043043.

    https://www.jacc.org/doi/10.1016/j.jacc.2023.08.017

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss rate versus rhythm control in patients with atrial fibrillation
    2. Develop a monitoring plan and selection of medications in rhythm control

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-030-H01-P
    Initial release date: 1/5/2024
    Expiration date: 1/5/2025
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, as he evaluates the first half of the guidelines in this two-part episode.

    The GameChanger
    Different stratifying types of atrial fibrillation no longer exist. Additionally, left atrial occlusive devices are now recommended as first-line therapy for the prevention of stroke, though anticoagulants are the treatment of choice.

    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)06465-3. doi: 10.1016/j.jacc.2023.08.017. Epub ahead of print. PMID: 38043043.

    https://www.jacc.org/doi/10.1016/j.jacc.2023.08.017

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Describe new definitions of atrial fibrillation and risk factors for stroke
    2. Discuss mechanical prevention of stroke in high risk patients

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-23-401-H01-P
    Initial release date: 12/25/2023
    Expiration date: 12/25/2024
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Join Ashlee as she talks with Ina, the Director of Clinical Operations at RxGenomix, about the fascinating world of pharmacogenomics. Throughout this episode, Ashlee and Ina get into the nitty-gritty of pharmacogenomic testing - a game-changer in ensuring the right medication is administered to the right patient at the right time and dose.

    Listen to this episode to equip yourself with the knowledge to grasp the potential and significance of pharmacogenomics in patient care. Whether a healthcare professional or simply curious, it's time to step into the future of personalized medicine.

    In this episode, the two discuss:
    - Pharmacogenomics & their implications
    - The role genetics play in influencing medication responses
    - Integrating pharmacogenomics into routine patient care
    - The future of pharmacogenomics

    Dr. Ina Liko received her Doctor of Pharmacy degree at the University of Illinois at Chicago where she was initially exposed to pharmacogenomics. She then completed a clinical residency program at Monroe Clinic where her research project was focused on the implementation of pharmacogenomics. After this initial exposure to the clinical application of pharmacogenomics, she gained experience in implementing it in a larger scale by completing a fellowship in the Clinical Implementation of Pharmacogenomics at the University of Colorado where she was exposed to a systematic approach of implementing pharmacogenomics in various therapeutic classes. Dr. Liko now serves as the Director of Clinical Pharmacogenomics Operations at RxGenomix where she works collaboratively in a multidisciplinary team leading the clinical operations.

    To learn more about CEimpact's By Design memberships, click here.
    To learn more about the CEimpact Advanced PGx training, click here

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • Utter the words "Artificial Intelligence" to other preceptors and pharmacy faculty, and you might get a reaction that ranges anywhere from fear and anxiety to excitement. In this insightful discussion, we explore the fundamental question of what AI is and its diverse application in shaping the landscape of pharmacy education. Guest Tim Aungst delves into the challenges surrounding student and resident access to AI tools, shedding light on the challenges and opportunities that access brings.

    Host
    Kathy Schott, PhD
    Vice President, Education & Operations
    CEimpact

    Guest
    Timothy Dy Aungst, PharmD, RPh
    Associate Professor of Pharmacy Practice
    Massachusetts College of Pharmacy and Health Sciences

    Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

    CPE Information

    Learning Objectives
    At the end of this course, preceptors will be able to:
    1. List a primary advantage of using artificial intelligence (AI)
    2. Discuss ways in which access to AI should inform teaching strategies.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-23-402-H99-P
    Initial release date: 12/20/2023
    Expiration date: 12/20/2024
    Additional CPE details can be found here.

    Dr. Schott has no relevant financial relationships with ineligible companies to disclose.

    Dr. Aungst reports he is a consultant for Otsuka and an advisor for Digital Therapeutics Alliance. All relevant financial relationships have been mitigated.

    This program has been:
    Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

    Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram

  • One of the oldest medications in our pharmacopeia is digoxin. It may be used for atrial fibrillation and heart failure, although not as a first-line agent. Despite this, digoxin use is on the rise. Join host, Geoff Wall, as he evaluates why more prescribers are using digoxin.

    The GameChanger
    No new randomized controlled trials have been published to justify the increased use of digoxin. However, when used, providers should routinely monitor digoxin levels.

    Host
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    Gazzaniga G, Menichelli D, Scaglione F, et al. Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses. Eur J Clin Pharmacol. 2023 Apr;79(4):473-483. doi: 10.1007/s00228-023-03470-y. Epub 2023 Mar 6. PMID: 36872367; PMCID: PMC10039090.

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039090/

    Pharmacist Members, REDEEM YOUR CPE HERE!

    Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


    CPE Information

    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Apply information on the potential uses and harms of digoxin
    2. Apply a strategy for monitoring digoxin in heart failure patients

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-23-400-H01-P
    Initial release date: 12/18/2023
    Expiration date: 12/18/2024
    Additional CPE details can be found here.

    Follow CEimpact on Social Media:
    LinkedIn
    Instagram